Everything NICE has said on preventing and controlling healthcare-associated infections in an interactive flowchart
Everything NICE has said on blood and bone marrow cancers including leukaemia in an interactive flowchart
Everything NICE has said on managing skin conditions and skin damage in an interactive flowchart
NICE news Our monthly newsletter, keeping you up-to-date with important developments at NICE. Subscribe for information on: our latest published and
Jump to: Our Stance on Frequently Asked Questions Our stance on: Statins Our guidance on the risk assessment and reduction
Biographies of the NICE senior management team and minutes of their meetings
We work with organisations to help to put our guidance into practice. We work with NHS, local authority and other organisations in their area,...
Shared Learning Award 2019 finalist
Shared Learning Award 2019 finalist
Shared Learning Award 2019 winner
Evidence-based recommendations on lead-I ECG devices for detecting symptomatic atrial fibrillation using single time point testing in primary care
Advice on Peezy Midstream for midstream urine (MSU) collection
Advice on DuraGraft for preserving vascular grafts used in coronary artery bypass graft (CABG) surgery to aid local decision making
Evidence-based recommendations on abemaciclib (Verzenios) for treating hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer
Advice on SEM Scanner for pressure ulcer prevention to aid local decision making
Training seminars and workshops for those in the pharmaceutical, medical technology or cell and gene therapy sectors
Designed for those seeking advice in either pharmaceutical or medical technologies. Provides the highest level of detail of all our advice processes.
Everything NICE has said on diagnosing and treating advanced breast cancer in an interactive flowchart
Everything NICE has said on diagnosing and managing atrial fibrillation in an interactive flowchart
Why seek advice? Our evaluation programmes require certain types of evidence about the technology being appraised. Our advice ensures that your...
Scientific advice medtech advice
Jump to: Stages in the purchasing process Stage 1: draft and agree your purchasing requirements Stage 2: get approval to buy what you need Stage
Provider name: Mark Allen Group Lot details Lot 1 - Electronic Journals Lot 2 - Electronic Journals Provider helpdesk
Information about NICE provider ProQuest
Provider name: Wiley Lot details Lot 1 - Print Journals, Electronic Journals, Print Books, Electronic Books Lot 2 - Print Journals, Electronic
Provider name: Wolters Kluwer Lot details Lot 1 - Electronic Journals, Electronic Books, Databases, Aggregated Evidence Resource Summaries
Our express service is designed for companies who need to receive scientific advice within more challenging timeframes. Within 12 weeks, you'll...
NICE block scoping reports
Information, meeting dates and minutes of the medical technologies advisory committee
Everything NICE has said on diagnosing and managing varicose veins in the legs in an interactive flowchart.
This guideline covers the management of Crohn’s disease in children, young people and adults. It aims to reduce people’s symptoms and maintain or improve their quality of life.
This guideline covers the management of ulcerative colitis in children, young people and adults. It aims to help professionals to provide consistent high-quality care and it highlights the importance of advice and support for people with ulcerative colitis.
Data on the recommendations made by our technology appraisal programme. Includes information on the number of positive recommendations we've made.
Data on the cancer recommendations made by our technology appraisal programme. Includes information on the number of positive recommendations we've made.
Provider name: LM info Lot details Lot 2 Agent - Print Journals, Electronic Journals, Databases, Aggregated Evidence Resource Summaries
The AAC product identification process and transformative designation status
Provider grid Details of the Content Resources and services offered by appointed Providers under the NICE Electronic and Print Content Framework....
The Accelerated Access Collaborative is a fast-track route into the NHS for “breakthrough” medicines and technologies
How to partner with NICE for your research.
Patient access schemes and the NICE Patient Access Liaison Unit When assessing new drugs and treatments, NICE looks at the cost of the treatment and...
How to submit a new medical technology to NICE for guidance
Everything NICE has said on diagnosing and managing irritable bowel syndrome in adults in primary care in an interactive flowchart
Everything NICE has said on managing Crohn's disease in children, young people and adults in an interactive flowchart
Everything NICE has said on managing ulcerative colitis in adults, children and young people in an interactive flowchart
Who is the accelerated access collaborative and what do they do?
Our tool to help you plan for and implement NICE guidance. View upcoming guidance and understand the impact of guidance on your resources. Previously known as the forward planner.
We estimate the costs or savings (budget impact) associated with technologies and guidelines so you can plan for and implement guidance.
NICE’s new guideline is the first to offer comprehensive information on neurological conditions to help non-specialist healthcare professionals to identify people who should be referred for specialist assessment and care.
This guideline covers the initial assessment of symptoms and signs that might indicate a neurological condition. It helps non-specialist healthcare professionals to identify people who should be offered referral for specialist investigation.
This guideline covers interventions in the acute stage of a stroke or transient ischaemic attack (TIA). It offers the best clinical advice on the diagnosis and acute management of stroke and TIA in the 48 hours after onset of symptoms.